Paul Steckler is the General Manager for Canopy Growth across international markets including Europe and APAC.
As General Manager, Paul leads the commercial strategy for Spectrum Therapeutics, Canopy Growth’s medical cannabis division, across Australia, Germany, the UK, Czech Republic, and Poland.
A seasoned pharmaceutical executive with over 20 years’ experience in commercial roles, Paul came to Canopy Growth having most recently served as Commercial Director at Pfizer. During his tenure with Pfizer, Paul successfully grew specialty brands from pre-launch to loss of exclusivity. Additionally, Paul oversaw a successful IPO while Chief Commercial Officer at Shield Therapeutics Plc., a London listed AIM specialty research-based pharmaceutical company, while simultaneously overseeing leading global commercial operations.
Paul has a BSc (Hons) Microbiology and Virology from the University of Warwick.Leadership Team